Advertisement
Advertisement
GMED
GLOBUS MEDICAL INC
86.10
USDSponsored
-0.20
-0.23%
Mar 20, 15:59 UTC -4
Closed
After-Market
87.03
+0.93
+1.08%
GMED Earnings Reports
Positive Surprise Ratio
GMED beat 27 of 41 last estimates.
66%
Next Report
Date of Next Report
May 01, 2026
Estimate for Q1 26 (Revenue/ EPS)
$751.28M
/$0.93
Implied change from Q4 25 (Revenue/ EPS)
-9.09%
/-27.34%
Implied change from Q1 25 (Revenue/ EPS)
+25.61%
/+36.76%
GLOBUS MEDICAL INC earnings per share and revenue
On Feb 24, 2026, GMED reported earnings of 1.28 USD per share (EPS) for Q4 25, beating the estimate of 1.17 USD, resulting in a 9.19% surprise. Revenue reached 826.42 million, compared to an expected 815.11 million, with a 1.39% difference. The market reacted with a +4.51% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 16 analysts forecast an EPS of 0.93 USD, with revenue projected to reach 751.28 million USD, implying an decrease of -27.34% EPS, and decrease of -9.09% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.08
Surprise
+36.51%
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.27
Surprise
-32.35%
Stereotaxis, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.06
Surprise
+10.04%
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.22
Surprise
+40.09%
Nuwellis, Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$1.59
Actual
-$1.50
Surprise
+5.73%
FAQ
What were GLOBUS MEDICAL INC's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, GLOBUS MEDICAL INC reported EPS of $1.28, beating estimates by 9.19%, and revenue of $826.42M, 1.39% above expectations.
How did the market react to GLOBUS MEDICAL INC's Q4 2025 earnings?
The stock price moved up 4.51%, changed from $90.54 before the earnings release to $94.62 the day after.
When is GLOBUS MEDICAL INC expected to report next?
The next earning report is scheduled for May 01, 2026.
What are the forecasts for GLOBUS MEDICAL INC's next earnings report?
Based on 16
analysts, GLOBUS MEDICAL INC is expected to report EPS of $0.93 and revenue of $751.28M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement